These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 24775638)
1. Down-regulation of asparagine synthetase induces cell cycle arrest and inhibits cell proliferation of breast cancer. Yang H; He X; Zheng Y; Feng W; Xia X; Yu X; Lin Z Chem Biol Drug Des; 2014 Nov; 84(5):578-84. PubMed ID: 24775638 [TBL] [Abstract][Full Text] [Related]
2. Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells. Yu Q; Wang X; Wang L; Zheng J; Wang J; Wang B Scand J Gastroenterol; 2016 Oct; 51(10):1220-6. PubMed ID: 27251594 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of asparagine synthetase by RNAi suppresses cell growth in human melanoma cells and epidermoid carcinoma cells. Li H; Zhou F; Du W; Dou J; Xu Y; Gao W; Chen G; Zuo X; Sun L; Zhang X; Yang S Biotechnol Appl Biochem; 2016 May; 63(3):328-33. PubMed ID: 25858017 [TBL] [Abstract][Full Text] [Related]
4. Loss of asparagine synthetase suppresses the growth of human lung cancer cells by arresting cell cycle at G0/G1 phase. Xu Y; Lv F; Zhu X; Wu Y; Shen X Cancer Gene Ther; 2016 Sep; 23(9):287-94. PubMed ID: 27444726 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle. Yang M; Gao H; Chen P; Jia J; Wu S Oncol Rep; 2013 Jul; 30(1):171-8. PubMed ID: 23624618 [TBL] [Abstract][Full Text] [Related]
7. Lentivirus-mediated knockdown of CEP55 suppresses cell proliferation of breast cancer cells. Wang Y; Jin T; Dai X; Xu J Biosci Trends; 2016 Feb; 10(1):67-73. PubMed ID: 26902787 [TBL] [Abstract][Full Text] [Related]
8. Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma. Zhang B; Dong LW; Tan YX; Zhang J; Pan YF; Yang C; Li MH; Ding ZW; Liu LJ; Jiang TY; Yang JH; Wang HY Br J Cancer; 2013 Jul; 109(1):14-23. PubMed ID: 23764751 [TBL] [Abstract][Full Text] [Related]
9. Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase. Hermanova I; Zaliova M; Trka J; Starkova J Exp Hematol; 2012 Aug; 40(8):657-65. PubMed ID: 22542578 [TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin. Cui H; Darmanin S; Natsuisaka M; Kondo T; Asaka M; Shindoh M; Higashino F; Hamuro J; Okada F; Kobayashi M; Nakagawa K; Koide H; Kobayashi M Cancer Res; 2007 Apr; 67(7):3345-55. PubMed ID: 17409444 [TBL] [Abstract][Full Text] [Related]
11. RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0/G1 cell cycle arrest in breast cancer cells. Han J; Zhang F; Yu M; Zhao P; Ji W; Zhang H; Wu B; Wang Y; Niu R Cancer Lett; 2012 Aug; 321(1):80-8. PubMed ID: 22381696 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of ER60 protease inhibits cellular proliferation by inducing G1/S arrest in breast cancer cells in vitro. Lwin ZM; Yip GW; Chew FT; Bay BH Anat Rec (Hoboken); 2012 Mar; 295(3):410-6. PubMed ID: 22266712 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-874 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting CDK9. Wang L; Gao W; Hu F; Xu Z; Wang F FEBS Lett; 2014 Dec; 588(24):4527-35. PubMed ID: 25281924 [TBL] [Abstract][Full Text] [Related]
14. Asparagine synthetase expression and its potential prognostic value in patients with NK/T cell lymphoma. Li Y; Zhang X; Hu T; Han L; Li R; Wen J; Zhang M Oncol Rep; 2014 Aug; 32(2):853-9. PubMed ID: 24913732 [TBL] [Abstract][Full Text] [Related]
16. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle. Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of NIT2 inhibits colon cancer cell proliferation and induces cell cycle arrest through the caspase-3 and PARP pathways. Zheng B; Chai R; Yu X Int J Mol Med; 2015 May; 35(5):1317-22. PubMed ID: 25738796 [TBL] [Abstract][Full Text] [Related]
18. Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer. Sircar K; Huang H; Hu L; Cogdell D; Dhillon J; Tzelepi V; Efstathiou E; Koumakpayi IH; Saad F; Luo D; Bismar TA; Aparicio A; Troncoso P; Navone N; Zhang W Am J Pathol; 2012 Mar; 180(3):895-903. PubMed ID: 22245216 [TBL] [Abstract][Full Text] [Related]
19. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2. Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135 [TBL] [Abstract][Full Text] [Related]
20. p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival. Deng L; Yao P; Li L; Ji F; Zhao S; Xu C; Lan X; Jiang P Nat Commun; 2020 Apr; 11(1):1755. PubMed ID: 32273511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]